Mechanism of Chemotherapy Resistance: a Comprehensive Review

Authors

  • Subash Paudel Trichandra Multiple Campus, Tribhuvan University Nepal, (M.Sc. Microbiology)
  • Laxmi Parajuli Trichandra Multiple Campus, Tribhuvan University Nepal, (M.Sc. Microbiology)
  • Santosh Shrestha University of Nebraska Medical Center, USA, (MS Cancer Research)
  • Indira Rai Nepal Medical College Teaching Hospital, Kathmandu, Nepal (MD Biochemistry)

DOI:

https://doi.org/10.3126/njc.v9i2.84910

Keywords:

cancer, chemotherapy, resistance, tumour microenvironment

Abstract

Chemotherapy resistance is a critical barrier to effective cancer treatment, contributing to the high number of cancers related death in patients. This review comprehensively examines the molecular mechanisms driving resistance, including innate and acquired resistance, tumor heterogeneity, and tumor microenvironment (TME) interactions. Key mechanisms include enhanced drug efflux via ABC transporters, increased DNA repair, altered drug targets, drug detoxification, and evasion of apoptosis. Tumor heterogeneity fosters resistant subclones, while TME factors like hypoxia and cancer-associated fibroblasts (CAFs) exacerbate resistance. Crosstalk between signaling pathways, such as PI3K/AKT and MAPK, fuels resistance but offers hope for combination therapies. Insights into these mechanisms are vital for developing targeted therapies to overcome resistance and improve patient outcomes.

Downloads

Download data is not yet available.
Abstract
36
PDF
13

Downloads

Published

2025-09-30

How to Cite

Paudel, S., Parajuli, L., Shrestha, S., & Rai, I. (2025). Mechanism of Chemotherapy Resistance: a Comprehensive Review. Nepalese Journal of Cancer, 9(2), 36–42. https://doi.org/10.3126/njc.v9i2.84910

Issue

Section

Review Articles